PUBLISHER: Grand View Research | PRODUCT CODE: 1493281
PUBLISHER: Grand View Research | PRODUCT CODE: 1493281
The U.S. PPG biosensors market size is anticipated to reach USD 340.1 million by 2030, registering a CAGR of 12.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The use of photoplethysmography (PPG) technology as an alternative heart rate monitoring strategy has increased rapidly due to the ease of use and cost-effectiveness, rising prevalence of cardiovascular disorders (CVDs), and high adoption of wearable devices & smart watches. Photoplethysmography technology offers flexibility, enabling its integration into various devices, such as watches, rings, patches, and earbuds. Several cardiac rhythm indicators, including heart rate (HR), heart rate variability (HRV), blood-volume saturation, and respiration rate (RR), had emerged as potential markers for COVID-19 infection.
Smart wearables equipped with PPG technology already measure these vital signs. In May 2019, Masimo received FDA clearance for its Tetherless Radius PPG sensors. These sensors enable the placement of point-of-care monitors outside a patient's room, ensuring constant monitoring from a safe distance. The increasing prevalence of CVDs is expected to be a major factor propelling the growth of this market over the forecast period. According to the CDC, approximately 695,000 of the U.S. inhabitants die from CVDs.